FDA approves expanded indication for medical device to treat a form of brain cancer
The FDA approved an expanded indication for the Optune device, made by Novocure, to treat patients with newly-diagnosed glioblastoma multiforme, an aggressive form of brain cancer. It is given along with the chemotherapy drug temozolomide following standard treatments. October 05, 2015